Literature DB >> 2167495

The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.

S H Morgan1, P Rudge, S J Smith, A M Bronstein, B E Kendall, E Holly, E P Young, M D Crawfurd, R Bannister.   

Abstract

Anderson-Fabry disease is an X-linked inborn error of metabolism characterized by subnormal activity of the lysosomal hydrolase, alpha-galactosidase A. We have assessed the incidence and nature of neuropathy in 12 patients (seven affected men and five carrier females). Abnormalities of cutaneous thermal sensation were common, even in asymptomatic carriers, with a unique predilection for cold sensitivity which suggests involvement of small myelinated nerve fibres. Intracranial abnormalities were frequently detected by magnetic resonance imaging (MRI) in males, both with and without overt cerebrovascular disease, and were more extensive in older patients. Such abnormalities were not detected in carriers. Auditory and vestibular abnormalities were present in six patients, only one of whom was symptomatic. Cranial MRI and assessment of cutaneous thermal thresholds are sensitive techniques which can identify neurological involvement in asymptomatic patients. They may be of benefit in monitoring the effectiveness of enzyme replacement therapy and excluding the carrier state for the defective gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167495

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  18 in total

Review 1.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 2.  Progressive hearing loss in Fabry's disease: a case report.

Authors:  Florian M Barras; Raphaël Maire
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-07       Impact factor: 2.503

3.  [Fabry's disease: new therapeutic options for this lysosomal storage disorder].

Authors:  A J Grau; M Schwaninger; H H Goebel; M Beck
Journal:  Nervenarzt       Date:  2003-05-20       Impact factor: 1.214

4.  Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

Authors:  C Whybra; C Kampmann; I Willers; J Davies; B Winchester; J Kriegsmann; K Brühl; A Gal; S Bunge; M Beck
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

5.  Tingling extremities in a young man.

Authors:  D J Goldsmith; I S Roberts; N P Mallick
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

6.  Electroneuromyographic Features in Fabry Disease: A Retrospective Review.

Authors:  Çetin Kürşad Akpinar; Hande Türker; Oytun Bayrak; Nilgün Cengiz
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

7.  Stroke in Fabry's disease.

Authors:  R P Grewal
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

8.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

9.  Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests.

Authors:  Marieke Biegstraaten; Ivo N van Schaik; Wouter Wieling; Frits A Wijburg; Carla E M Hollak
Journal:  BMC Neurol       Date:  2010-06-07       Impact factor: 2.474

10.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.